|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 16/09/14 | CHUGAI PHARMACEUTICAL : Roche's $8 billion InterMune buy not a signal for more big deals | RE |
| 04/09/14 | Roche : rules out mega deals, open to smaller ones - paper | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Thompson
CEO | Chief Executive Officer | 57 | - |
| Chief Tech/Sci/R&D Officer | 71 | 01/04/2002 | |
Carla Fiankan
LAW | General Counsel | - | 01/08/2011 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.65% | -3.36% | +36.98% | +60.50% | 64.14B | ||
| +1.31% | +3.04% | +12.64% | +84.55% | 55.53B | ||
| +1.22% | +1.40% | +12.62% | +104.49% | 53.03B | ||
| +2.76% | +0.87% | +27.92% | +55.07% | 45.99B | ||
| +2.00% | -3.39% | +17.83% | +119.04% | 42.45B | ||
| +1.34% | -2.86% | +224.43% | +914.08% | 40.45B | ||
| +0.64% | -3.95% | +11.15% | +45.57% | 32.25B | ||
| -1.85% | +42.20% | +103.01% | +89.55% | 34.47B | ||
| -2.72% | -0.44% | +23.18% | -10.77% | 24.23B | ||
| Average | +0.59% | +4.08% | +52.20% | +162.45% | 43.62B | |
| Weighted average by Cap. | +0.85% | +3.49% | +49.26% | +160.42% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
















